Cancer Genomics for the Clinician

ホーム
> 洋書
> 英文書
> Medical

個数：

Cancer Genomics for the Clinician

Govindan, Ramaswamy (EDT)/ Devarakonda, Siddhartha (EDT)

ウェブストア価格 ¥12,710（本体¥11,555）
Springer Publishing Co Inc（2019/01発売）
外貨定価 US$ 61.00
ポイント 115pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 184 p.
言語 ENG
商品コード 9780826168672
DDC分類 616.994042

Full Description

Cancer Genomics for the Clinician is a practical guide to cancer genomics and its application to cancer diagnosis and care. The book begins with a brief overview of the various types of genetic alterations that are encountered in cancer, followed by accessible and applicable information on next generation sequencing technology and bioinformatics; tumor heterogeneity; whole genome, exome, and transcriptome sequencing; epigenomics; and data analysis and interpretation. Each chapter provides essential explanations of concepts, terminology, and methods. Also included are tips for interpreting and analyzing molecular data, as well as a discussion of molecular predictors for targeted therapies covering hematologic malignancies and solid tumors. The final chapter explains the use of FDA-approved genomic-based targeted therapies for breast cancer, lung cancer, sarcomas, gastrointestinal cancers, urologic cancers, head and neck cancer, thyroid cancer, and many more.

Assembled in an accessible format specifically designed for the non-expert, this book provides the clinical oncologist, early career practitioner, and trainee with an essential understanding of the molecular and genetic basis of cancer and the clinical aspects that have led to advancements in diagnosis and treatment. With this resource, physicians and trainees will increase their breadth of knowledge and be better equipped to educate patients and families who want to know more about their genetic predispositions to cancer and the targeted therapies that could be considered and prescribed.

Key Features:

Describes how cancer genomics and next generation sequencing informs cancer screening, risk factors, therapeutic options, and clinical management across cancer types
Explains what mutations are, what tests are needed, and how to interpret the results
Provides information on FDA-approved targeted therapies that are being used in the clinic
Covers different sequencing platforms and technologies and how they perform in research settings
Includes access to the fully searchable eBook

Contents

Contributors

Preface

Acknowledgments

1. Genetic Alterations in Cancer

Deepali Jain, Brett H. Herzog, and Leonard B. Maggi, Jr.

2. Tumor Mutational Profiling by Next-Generation Sequencing

Samantha N. McNulty, Latisha Love-Gregory, and Jonathan W. Heusel

3. Bioinformatics: What a Clinician Should Know

Irena Lanc and Arpad Danos

4. Tumor Heterogeneity

Alex H. Wagner, Kilannin Krysiak, Katie M. Campbell, and Erica K. Barnell

5. Epigenetic Alterations in Cancer

Erica C. Pehrsson, Hyo Sik Jang, and Ting Wang

6. Cell-Free DNA in Cancer Diagnosis and Follow Up

Bruna Pellini Ferreira and Daniel Morgensztern

7. Optimizing Targeted Therapies Using Next-Generation Sequencing

Brett H. Herzog and Saiama N. Waqar

Index